Cerus Submits the First of Three Modules in the Premarket Approval (PMA) Application Process for INT
CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NAS: CERS) announced today that it has submitted the first of three modules for its Premarket Approval (PMA) application to the U.S. Food and Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results